Bliss GVS Pharma Ltd (BLIS)

Currency in INR
381.10
+63.50(+19.99%)
Delayed Data·
Unusual trading volume
Trading near 52-week High
BLIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
320.65381.10
52 wk Range
118.35381.10
Key Statistics
Bid/Ask
381.10 / 380.05
Prev. Close
317.6
Open
321
Day's Range
320.65-381.1
52 wk Range
118.35-381.1
Volume
1.19M
Average Volume (3m)
102.78K
1-Year Change
202.9412%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLIS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Bliss GVS Pharma Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
10-02-2026
EPS / Forecast
2.14 / --
Revenue / Forecast
2.18B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.19%
Dividend Yield
0.31%
Industry Median 0.70%
Annualised payout
1.00
Paid unevenly
5-Years Growth
-
Growth Streak

BLIS Income Statement

Compare BLIS to Peers and Sector

Metrics to compare
BLIS
Peers
Sector
Relationship
P/E Ratio
30.8x20.9x−0.5x
PEG Ratio
0.380.150.00
Price/Book
3.0x1.9x2.6x
Price / LTM Sales
3.9x1.5x3.1x
Upside (Analyst Target)
-20.7%52.5%
Fair Value Upside
Unlock15.7%6.0%Unlock

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Employees
966
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.06M1.00%336.72M
Other Institutional Investors
30.35M28.69%9.64B
Public Companies & Retail Investors
74.38M70.31%23.62B
Total
105.79M100.00%33.6B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Life Insurance Corporation of India5.78%61,13,59819,41,679
Gulbarga Trading & Investments Pvt. Ltd.5.51%58,32,00018,52,243
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.